CSL is investigating two potential new treatments for sickle cell disease: An injected monoclonal antibody designed to ...

The U.S. Food and Drug Administration is speeding up its review of an oral medicine for sickle cell disease that may fill a ...

Columnist Oluwatosin Adesoye once feared how sickle cell complications would affect her future, but they ended up opening ...

Wilson reflects on the fruits of progress in sickle cell advocacy, leading to a new generation of possibility.

Sickle cell disease (SCD) prognosis varies depending on disease severity and other factors, but the overall life expectancy for the inherited blood disorder has increased notably over recent decades.

Mutations in the HBB gene cause SCD by leading to the production of a faulty version of hemoglobin (the protein that helps red blood cells transport oxygen), which tends to clump inside red blood ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google For individuals living with sickle cell disease (SCD), daily life ...

A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD) learn about and communicate with their care team about their pain attacks. People with ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google In a society that’s seemingly obsessed with sex and physical ...

Casgevy (exagamglogene autotemcel) is now approved in the U.S. to treat children as young as 2 with sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOCs). The U.S. Food and Drug ...

Beam Therapeutics plans to ask the U.S. Food and Drug Administration (FDA) to approve ristoglogene autogetemcel, or risto-cel, its single-dose, gene-edited cell therapy candidate for people with ...